Bethesda, Md., May 28, 2015 – The Parenteral Drug Association (PDA) proudly announces that it will be a supporting organization of the Johnson & Johnson Kilmer Conference on sterility assurance and sterilization in 2016.
Johnson & Johnson (J&J) is reviving the conference after a series of high-profile superbug infections in endoscopes. J&J ran 8 conferences on sterilization, validation and world health issues between 1976 and 2003 on advances in sterilization and other topics.
PDA joins the Association for the Advancement of Medical Instrumentation (AAMI) as a supporting organization of the May 2016 event.
PDA President and CEO Richard Johnson credits J&J for reviving this important event at a time when sterility assurance remains a critical issue. "PDA is pleased that J&J is resuming Kilmer Conference in 2016. PDA members across the globe are experts in the area of sterilization and sterility assurance for pharmaceutical products, and we are proud to be able to support this effort. Like J&J, PDA has spearheaded efforts to bring the latest in sterilization technology and science to the pharma industry, and the focus of many of our publications, conferences and training courses is in this area."